# Diluting With Cerebrospinal Fluid Versus Traditional Intrathecal Administration: Antishivering Effects

> **NCT02189655** · NA · WITHDRAWN · sponsor: **China Medical University, China**

## Conditions studied

- Antishivering Effects

## Interventions

- **PROCEDURE:** bupivacaine 0.5% 2.5 mL diluting with cerebrospinal fluid

## Key facts

- **NCT ID:** NCT02189655
- **Lead sponsor:** China Medical University, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-03
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02189655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02189655, "Diluting With Cerebrospinal Fluid Versus Traditional Intrathecal Administration: Antishivering Effects". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02189655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*